Association of WWOX rs9926344 polymorphism with poor prognosis of hepatocellular carcinoma.
Association of WWOX rs9926344 polymorphism with poor prognosis of hepatocellular carcinoma.
复制标题
WWOX rs9926344多态性与肝细胞癌不良预后的关系
DOI:
10.7150/jca.23808
复制
发表时间:
2018
影响因子:
3.9
通讯作者:
Ren N
中科院分区:
文献类型:
--
作者:
Chen W;Zhou C;Zhang W;Atyah M;Yin Y;Guo L;Tang W;Dong Q;Ye Q;Ren N
Introduction: The WW domain-containing oxidoreductase (WWOX), widely expressed in human tissues, is considered as a tumor suppressor gene and plays an important role in the incidence and progression of human cancer, HCC included. This study was to investigate the correlation between single nucleotide polymorphisms (SNPs) of the WWOX gene and the prognosis of hepatocellular carcinoma (HCC) patients. Materials and Methods: After a total of 152 HCC patients were recruited, 8 cases with tumor recurrence within 2-years after operation and 8 cases without recurrence were selected randomly for SNP genotyping and screening using Affymetrix Array 6.0. And then we confirmed candidate SNPs in the remaining 136 patients by time-of-flight mass spectrometry (TOF-MS). Results: In total, 32 SNPs were screened and identified as candidate SNPs with one SNP in particular, (rs9926344), being further verified to be valuable. We found that AA+AG genotype and A allele of WWOX rs9926344 were significantly associated with recurrent risk of HCC (p=0.002 and p=0.001, respectively). The Kaplan-Meier curve showed that patients carrying rs9926344 AA +AG genotype had poor RFS (P=0.004) and OS (P=0.005) compared to those carrying GG genotypes. The multivariate COX regression analysis showed that the AA+AG genotype were an independent prognostic factor for tumor recurrence (HR 1.787, 95% CI 1.042-3.064, P=0.035). Furthermore, IHC analysis showed that the WWOX protein down-regulation is more frequent in patients with AG genotype compared to those with GG genotype (P=0.023). Conclusion: Our findings indicate that WWOX rs9926344 polymorphism is positively correlated with tumor recurrence and can be used as an independent prognostic marker for HCC patients after operation.
登录
查看更多内容
影响因子:
29.4
作者:
El-Serag HB
通讯作者:
El-Serag HB
影响因子:
3.7
作者:
Lee HL;Cheng HL;Liu YF;Chou MC;Yang SF;Chou YE
通讯作者:
Chou YE
影响因子:
1.3
作者:
Liu W;Golovatch S;Tian M
通讯作者:
Tian M
影响因子:
2.8
作者:
Guo, Wei;Dong, Zhiming;Yang, Zhibin
通讯作者:
Yang, Zhibin
DOI:
10.1073/pnas.1315934110
发表时间:
2013-10-15
影响因子:
11.1
作者:
Gonzalez-Garay, Manuel L.;McGuire, Amy L.;Caskey, C. Thomas
通讯作者:
Caskey, C. Thomas